Abstract:Background The use of Mohs micrographic surgery (MMS) in melanoma treatment has divided opinion and evidence‐based guidelines are lacking. Objectives This systematic review aimed to analyse clinical outcomes for patients with invasive melanomas treated with Mohs rather than wide local excision (WLE). Methods Embase, MEDLINE and Cochrane databases (to 30 August 2023) were searched for studies using Mohs to treat invasive melanoma. Outcomes of interest were local recurrence and death from melanoma. Results Thirty‐five articles involving 41,499 patients with invasive melanoma treated with Mohs were identified. Sixteen studies compared Mohs with WLE and 19 were Mohs‐only, non‐comparative studies. Patients treated with Mohs differed significantly from those undergoing WLE, in particular Mohs patients were older and had thinner melanomas. Two comparative studies using the same data source reported adjusted hazard ratios for melanoma‐specific death and both showed no significant difference between Mohs and WLE‐treated patients; 0.87 (95% CI 0.55–1.35) and 1.20 (95% CI 0.71–20.36). There was also no statistically significant difference in local recurrence risk; the unadjusted risk ratio for patients treated with Mohs was 0.46 (95% CI 0.14–1.51 p = 0.20) with moderate heterogeneity (I2 = 62%). No studies reported multivariable analyses for risk of local recurrence. Many studies generated from relatively few and often overlapping data sets have reported the use of Mohs to treat patients with invasive melanoma. Fewer studies were comparative between Mohs and WLE and these reported substantially different baseline risks of recurrence and death from melanoma between the groups. Mohs has generally been used for thinner melanomas in older patients; therefore, comparisons based on univariable analyses are likely to have been misleading. Conclusions On the basis of currently available data, it is not possible to reliably assess whether outcomes differ if invasive melanomas with comparable features are treated with Mohs or WLE, and randomized trial evidence will be required for reliable conclusions to be reached.

Mohs Micrographic Surgery: A Brief Overview

A review of Mohs micrographic surgery for skin cancer. Part 1: Melanoma and rare skin cancers

Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors

Mohs Micrographic Surgery in the Surgical Treatment Paradigm of Melanoma In Situ and Invasive Melanoma: A Clinical Review of Treatment Efficacy and Ongoing Controversies

Surgical Margins of Nonmelanoma Skin Cancers in Mohs Surgery: Dermoscopy Versus Naked Eye

Mohs Micrographic Surgery for Invasive Melanoma Allows for Tissue Preservation Compared With Wide Local Excision: A Retrospective Cohort Study

Using optical coherence tomography to optimize Mohs micrographic surgery

Mohs micrographic technique in high-risk basal cell carcinoma: a 3D prediction of safety margins

Mohs micrographic surgery challenges and new technologies to optimize care of cutaneous malignancies of the ear

Clinical Versus Histologic Margins for Cutaneous Squamous Cell Carcinoma: Comparing Outcomes for High-Risk Tumors Treated With Mohs Micrographic Surgery

Removal of Incidental Skin Cancer During Mohs Micrographic Surgery Indicated for a Different Primary Tumor

Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review

Histopathology for Mohs Micrographic Surgery with Photoacoustic Remote Sensing Microscopy

[Modified Mohs Micrographic Surgery in the Treatment of Cutaneous Melanoma].

micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities

DS18 Pre-Mohs biopsy survey (related specifically to basal cell carcinoma and biopsy prior to Mohs surgery)

Mohs for Melanoma: A Review of MART-1 Frozen Section Interpretation

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta‐analyses

Oncologic control and predictors of urologic reconstruction after Mohs micrographic surgery for low-risk penile malignancy

Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study